The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Executive summary

Xenotransplantation

Volumn 16, Issue 4, 2009, Pages 196-202

  Hering, Bernhard J ^a   Cooper, David K C ^b   Cozzi, Emanuele ^c   Schuurman, Henk Jan ^d   Korbutt, Gregory S ^e   Denner, Joachim ^f   O'Connell, Philip J ^g   Vanderpool, Harold Y ^h   Pierson Iii, Richard N ⁱ  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d Spring Point Project   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f ROBERT KOCH INSTITUTE   (Germany)

^g UNIVERSITY OF SYDNEY   (Australia)

^h UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁱ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPTUAL FRAMEWORK; CONSENSUS DEVELOPMENT; HUMAN; INFORMED CONSENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MATERIALS TESTING; MEDICAL ETHICS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; VIRUS TRANSMISSION; XENOTRANSPLANTATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; INFORMED CONSENT; INTERNATIONAL COOPERATION; ISLETS OF LANGERHANS TRANSPLANTATION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; SWINE; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 70349606907     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2009.00547.x     Document Type: Review

References (28)

1. Cozzi E, Tallacchini MC, Pierson RN, Sykes M, Vanderpool HY. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework. Xenotransplantation 2009 16 : 203 214.
2. Rood PPM, Cooper DKC. Islet xenotransplantation: are we really ready for clinical trials? Am J Transplant 2006 6 : 1269 1274.
3. Groth CG, Korbutt GS, Hering BJ et al. A consensus document based on the pig-to-man islet transplant summit held in Stockholm, June 4-5, 2007. Xenotransplantation 2008 15 : 79.
4. Interim IXA Recommendations for Clinical Islet Xenograft Trials. 2008. Available at: http://www.transplantation-soc.org/downloads/IXA-Islet-guidance-2- 17-08.pdf (accessed on 22 July 2009).
5. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006 12 : 301 303.
6. Cardona K, Korbutt GS, Milas Z et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006 12 : 304 306.
7. Gianello P, Dufrane D. Correction of a diabetes mellitus type 1 on primate with encapsulated islet of pig pancreatic transplant. Bull Mem Acad R Med Belg 2007 162 : 439 449.
8. Hecht G, Eventov-Friedman S, Rosen C et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A 2009 106 : 8659 8664.
9. Van Der Windt DJ, Bottino R, Casu A et al. Diabetic nonhuman primates transplanted with hCD46 transgenic porcine islets maintain long-term normoglycemia under limited immunosuppression. Am J Transplantation (in press).
10. Schuurman HJ. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 2: Source pigs. Xenotransplantation 2009 16 : 215 222.
11. Korbutt GS. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 3: Pig islet product release criteria. Xenotransplantation 2009 16 : 223 228.
12. Cooper DKC, Casu A. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009 16 : 229 238.
13. Denner J, Schuurman HJ, Patience C. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009 16 : 239 248.
14. O'Connell PJ. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation. Xenotransplantation 2009 16 : 249 254.
15. Vanderpool HY. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 7: Informed consent and xenotransplantation clinical trials. Xenotransplantation 2009 16 : 255 262.
16. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004 4 : 1383 1390.
17. Sykes M, D'Apice A, Sandrin M. Position paper of the Ethics Committee of the International Xenotransplantation Association. Xenotransplantation 2003 10 : 194 203.
18. World Health Organization. First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials. Changsha : The Changsha Communiqué, 2008. Available at: http://www.who.int/transplantation/xeno/ ChangshaCommunique.pdf (accessed on 22 July 2009).
19. World Health Organization. World Health Organization Resolution WHA 57.18 on Human Organ and Tissue Transplantation (Allogeneic and Xenogeneic Transplantation). 2004. Available at: http://www.who.int/gb/ebwha/pdf-files/ WHA57/A57-R18-en.pdf (accessed on 22 July 2009).
20. Sykes M, Sandrin M, Cozzi E, Rees MA. World Health Organization resolution on xenotransplantation. Xenotransplantation 2004 11 : 224 225.
21. U.S. Food and Drug Administration. Application of Current Statutory Authorities to Human Somatic Cell Therapy Products and Gene Therapy Products: Notice 1993 58 FR 53248. 1993. Available at: http://www.fda.gov/downloads/ BiologicsBloodVaccines/SafetyAvailability/UCM148113.pdf (accessed on 22 July 2009).
22. Kessler DA, Siegel JP, Noguchi PD et al. Regulation of somatic-cell therapy and gene therapy by the food and drug administration. N Engl J Med 1993 329 : 1169 1173.
23. Public Health Service Act. Title 42, USC 262, 351. 2009. Available at: http://www.kenyon.com/Resources/WaxmanHatchRH/HTMLHelp/!SSL!/WebHelp/html/ 42-U-S-C--262-Regulation-of-biological-products.htm (accessed on 20 August 2009).
24. U.S. Food and Drug Administration. Federal Food, Drug and Cosmetic Act. Title 21, U.S.C. 321. 2009. Available at: http://www.fda.gov/ RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/ FDCActChaptersIandIIShortTitleandDefinitions/ucm086297.htm (accessed on 22 July 2009).
25. Weber DJ, McFarland RD, Irony I. Selected Food and Drug Administration review issues for regulation of allogeneic islets of Langerhans as somatic cell therapy. Transplantation 2002 74 : 1816 1820.
26. U.S. Food and Drug Administration. Guidance for Industry: Guidance for Human Somatic Cell Therapy and Gene Therapy. 1998. Available at: http://www.fda.gov/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/ ucm072987.htm (accessed on 22 July 2009).
27. U.S. Food and Drug Administration. Guidance for Industry: Considerations for Allogeneic Pancreatic Islet Cell Products. 2008. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ UCM166165.pdf (accessed on 22 July 2009).
28. U.S. Department of Health and Human Services Secretary's Advisory Committee on Xenotransplantation. Informed Consent in Clinical Research Involving Xenotransplantation. 2004. Available at: http://www.transplantation- soc.org/downloads/SACX-informed-consent.pdf (accessed on 20 July 2009).